LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 25.62 | 770.25 | 2477 | 2514 | 0.9849 | 0.9823 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 25.62 | 770.25 | 2415 | 2514 | 0.9603 | 0.9531 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 27.84 | 770.25 | 2704 | 2833 | 0.9542 | 0.9507 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 27.84 | 770.25 | 2752 | 2833 | 0.9711 | 0.9690 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 30.06 | 770.25 | 2983 | 3106 | 0.9604 | 0.9602 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 30.06 | 770.25 | 3078 | 3106 | 0.9910 | 0.9910 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 32.28 | 770.25 | 3210 | 3392 | 0.9461 | 0.9489 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 32.28 | 770.25 | 3370 | 3392 | 0.9933 | 0.9937 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 34.50 | 770.25 | 3564 | 3712 | 0.9601 | 0.9645 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 34.50 | 770.25 | 3645 | 3712 | 0.9820 | 0.9840 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 36.73 | 770.25 | 3972 | 4086 | 0.9721 | 0.9766 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 36.73 | 770.25 | 3936 | 4086 | 0.9633 | 0.9691 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 38.95 | 770.25 | 4360 | 4543 | 0.9595 | 0.9680 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 38.95 | 770.25 | 4294 | 4543 | 0.9450 | 0.9563 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.17 | 770.25 | 4865 | 5010 | 0.9709 | 0.9783 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 41.17 | 770.25 | 4756 | 5010 | 0.9492 | 0.9618 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.39 | 770.25 | 5193 | 5404 | 0.9609 | 0.9718 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 43.39 | 770.25 | 5256 | 5404 | 0.9726 | 0.9803 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.61 | 770.25 | 5519 | 5813 | 0.9494 | 0.9647 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 45.61 | 770.25 | 5640 | 5813 | 0.9702 | 0.9794 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.83 | 770.25 | 5953 | 6223 | 0.9565 | 0.9707 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 47.83 | 770.25 | 5963 | 6223 | 0.9581 | 0.9718 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 50.05 | 770.25 | 6447 | 6629 | 0.9725 | 0.9821 | MN20160304_L02 | D22 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 50.05 | 770.25 | 6354 | 6629 | 0.9584 | 0.9729 | MN20160304_L02 | I04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 52.27 | 770.25 | 6963 | 7058 | 0.9864 | 0.9915 | MN20160304_L02 | D22 |